Data / Form D filings / Kate Therapeutics Inc.
Kate Therapeutics Inc.: Form D filings
Kate Therapeutics Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC in 2024. The latest, on August 7, 2024, reports $21.8 million sold of a $23.4 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10675 SORRENTO VALLEY ROAD, SUITE 150, San Diego, CA, 92121
- Phone
- (619) 614-3609
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2032702
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2024 | New notice | $23,363,910 | $21,775,022 | $1,588,888 | 8 | May 17, 2024 | sec.gov |
| Aug 7, 2024 | New notice | $35,000,000 | $35,000,000 | 5 | Aug 31, 2021 | sec.gov | |
| Aug 7, 2024 | New notice | $16,000,000 | $16,000,000 | 1 | Feb 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Clare Ozawa, Ph.D. | Director | |
| Kevin Forrest, Ph.D. | Executive Officer, Director | |
| Beth Seidenberg, M.D. | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 5, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kate Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.